Symposium:
179. Novel Insights into Host Defense during Fungal Infection
Friday, October 9, 2015: 3:45 PM-5:45 PM
Room: 6--CF
Co-organized with the National Institute of Allergy and Infectious Diseases

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • describe the molecular and cellular mechanisms by which the mammalian immune system responds to fungal challenge
  • identify important genetic syndromes that result in inherited susceptibility to fungal disease

Target Audience: Vaccinologists, Scientists, Researchers, Investigators, Infectious diseases physicians, Infectious diseases pediatricians, HIV specialists, HIV clinicians, Fellows, Clinicians, Academicians

Tracks: Trainee, Pediatric ID, Investigative ID, Adult ID, HIV-STD-TB

Moderators:  Michail Lionakis, MD, ScD, National Institutes of Health and Eleftherios Mylonakis, MD, PhD, FIDSA, Rhode Island Hospital

Presentations:
3:45 PM
1287
Inborn Errors of Antifungal Immunity
Steven Holland, MD

4:15 PM
1288
Epigenetic Reprogramming of Mononuclear Phagocytes during Fungal Infection
Frank Van De Veerdonk Jr., MD, PhD
4:45 PM
1289
Fungal Vaccine Development and Immune Evasion by Fungi
Bruce Klein, MD
5:15 PM
1290
Intracellular Fate of Fungi
Jatin Vyas, MD, PhD, FIDSA

CME Credits: Maximum of 2.0 hours of AMA PRA Category 1 CreditTM

ACPE Credits: No CPE credit is offered for this session

ACPE Number:

Disclosures:

M. Lionakis, None

E. Mylonakis, T2 biosystems: Grant Investigator , Research grant
Astellas Pharma: Board Member and Grant Investigator , Consulting fee and Grant recipient
Boehringer Ingelheim: Grant Investigator , Research grant

See more of: Symposium
<< Previous Session | Next Session >>

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.